Wuhan Keqian BiologyLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Mulin Chen
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.4yrs |
| CEO ownership | n/a |
| Management average tenure | 11.2yrs |
| Board average tenure | 11.2yrs |
Recent management updates
Recent updates
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Pretty Healthy Balance Sheet
Jan 04
The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More
Oct 09These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well
Sep 26Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)
Aug 20We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt
Jun 26Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company
Apr 08Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be
Apr 05Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts
Apr 03Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet
Mar 20CEO
Mulin Chen (37 yo)
Ms. Mulin Chen is General Manager of Wuhan Keqian Biology Co.,Ltd from June 04, 2018 and was its Board Secretary since May 2013 until May 2022. She is Chairman of Wuhan Keqian Biology Co.,Ltd from July 05,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 7.4yrs | CN¥1.64m | no data | |
| CFO, Deputy GM & Vice Chairman | 2.3yrs | CN¥1.69m | no data | |
| Board Secretary | 3.5yrs | CN¥600.40k | no data | |
| Deputy General Manager | 11.2yrs | CN¥1.75m | no data | |
| Deputy General Manager | 11.2yrs | CN¥4.00m | no data | |
| Executive Deputy General Manager | 11.2yrs | CN¥2.35m | no data |
Experienced Management: 688526's management team is seasoned and experienced (11.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 2.3yrs | CN¥1.64m | no data | |
| CFO, Deputy GM & Vice Chairman | 2.3yrs | CN¥1.69m | no data | |
| Director | 24.9yrs | no data | 7.15% CN¥ 550.0m | |
| Supervisory Board Chairman | 24.9yrs | no data | 7.15% CN¥ 550.0m | |
| Director | 15.6yrs | no data | 7.15% CN¥ 550.0m | |
| Supervisor | 25.6yrs | no data | 5.54% CN¥ 426.2m | |
| Director | 5yrs | no data | no data | |
| Independent Director | 5yrs | CN¥100.00k | no data | |
| Independent Director | 5yrs | CN¥100.00k | no data | |
| Supervisor | 11.2yrs | no data | no data | |
| Director | 11.2yrs | no data | 6.16% CN¥ 474.0m |
Experienced Board: 688526's board of directors are seasoned and experienced ( 11.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 18:43 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wuhan Keqian Biology Co.,Ltd is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xie Zhiyou | China Galaxy Securities Co., Ltd. |
| Siyang Wang | China International Capital Corporation Limited |
| Xia Sheng | Citic Securities Co., Ltd. |